Stampidine is primarily investigated for its potential antiviral applications, particularly in the treatment of HIV. It has shown promise as a nucleoside reverse transcriptase inhibitor (NRTI), which helps in blocking the replication of the virus. Research has focused on its efficacy in reducing viral load and improving immune function in preclinical studies. Additionally, its unique chemical structure may offer advantages in overcoming drug resistance, making it a candidate for further development in antiretroviral therapy. However, its clinical application is still under investigation, and more studies are needed to confirm its safety and effectiveness in humans.